The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A single-arm phase II trial evaluating docetaxel, vinorelbine, and GM-CSF in stage IV melanoma.
J. P. Fruehauf
No relevant relationships to disclose
Z. Eroglu
No relevant relationships to disclose
K. M. Kong
No relevant relationships to disclose
J. G. Jakowatz
No relevant relationships to disclose
W. L. Akerley
No relevant relationships to disclose
W. E. Samlowski
No relevant relationships to disclose